PD-L1 and immune infiltrates are differentially expressed in distinct subgroups of gastric cancer
Authors:
Open Access
- 5 November 2018
- journal article
- research article
- Published by Taylor & Francis in OncoImmunology
- Vol. 8 (2) , e1544442
Abstract
This study investigates the association of PD-L1 expression and immune cell infiltrates and their impact on clinical outcome, in addition to their overlap with microsatellite instability (MSI), HER2 and ATM molecular subgroups of gastric cancer (GC). PD-L1 membrane expression on tumour cells (TC) and infiltrating immune cells (IC), CD3 + T-lymphocytes, CD8+ cytotoxic T-cells, ATM and HER2 were assessed by immunohistochemistry (IHC) in the ACRG (Asian Cancer Research Group) GC cohort (N = 380). EBV status was determined using in situ hybridization and MSI status was performed using PCR and MLH1 IHC. The PD-L1 segment was associated with increased T-cell infiltrates, while the MSI-high segment was enriched for PD-L1, CD3, and CD8. Multivariate analysis confirmed PD-L1 positivity, high CD3 and high CD8 as independent prognostic factors for both disease-free survival and overall survival (all p < 0.05). Patients with MSI-high tumours had better overall survival by both univariate and multivariate analysis. The ATM-low and HER2-high subgroups differed markedly in their immune profile; the ATM-low subgroups enriched for MSI, PD-L1 positivity and CD8 + T-cells, while the HER2 segment was enriched for MSS, with no enrichment for immune markers. Hence, we demonstrate a molecular profiling approach that can divide GC into four molecular subgroups, namely ATM-low, HER2-high, PD-L1 positive and MSI-high with differing levels of immune infiltrates and prognostic significance which may help to stratify patients for response to targeted therapies.Keywords
Funding Information
- Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI16C1990, HI14C3418)
- 20 by 20 project of Samsung Medical Centre (GF01140111)
This publication has 45 references indexed in Scilit:
- ATM signalling and cancerOncogene, 2013
- Ataxia‐telangiectasia‐mutated protein expression with microsatellite instability in gastric cancer as prognostic markerInternational Journal of Cancer, 2013
- From the immune contexture to the Immunoscore: the role of prognostic and predictive immune markers in cancerCurrent Opinion in Immunology, 2013
- Chronic renoprotective effect of pulsatile perfusion machine RM3 and IGL-1 solution in a preclinical kidney transplantation modelJournal of Translational Medicine, 2012
- Cancer classification using the Immunoscore: a worldwide task forceJournal of Translational Medicine, 2012
- The Heterochromatic Barrier to DNA Double Strand Break Repair: How to Get the Entry VisaInternational Journal of Molecular Sciences, 2012
- Advances in the Management of HER2-positive Advanced Gastric and Gastroesophageal Junction CancerJournal of Clinical Gastroenterology, 2012
- Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunityCurrent Opinion in Immunology, 2012
- Tumor-associated myeloid cells can be activated in vitro and in vivo to mediate antitumor effectsCancer Immunology, Immunotherapy, 2012
- DNA damage-induced activation of ATM and ATM-dependent signaling pathwaysDNA Repair, 2004